Page last updated: 2024-08-16

prednisolone and s 1033

prednisolone has been researched along with s 1033 in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's5 (71.43)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Matsunaga, T1
Butterfield, JH; Weiler, CR1
Go, SI; Kang, JH; Kang, MH; Kim, HG; Lee, GW; Lee, JH; Lee, WS1
Ahn, JS; Chi, HS; Cho, YU; Chung, JS; Eom, HS; Hyun, MS; Jang, S; Joo, YD; Jung, CW; Kim, DH; Kim, DY; Kim, H; Kim, I; Kim, K; Kim, KH; Kim, SD; Kim, YS; Lee, GW; Lee, H; Lee, HS; Lee, JH; Lee, JJ; Lee, KH; Lee, SM; Lee, WS; Lim, SN; Moon, JH; Mun, YC; Park, CJ; Park, J; Park, JH; Park, S; Shin, HJ; Sohn, SK; Won, JH; Yang, DH; Yoon, SS1
Akagawa, N; Higashihara, M; Iizuka, T; Ishida, T; Miyata, T; Miyazaki, K; Suzuki, T; Tominaga, N1
Cho, JY; Kim, D; Kwon, J; Lee, OJ; Shin, YM1

Reviews

3 review(s) available for prednisolone and s 1033

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
[Clinical progress in chronic myelogenous leukemia].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2009, Volume: 50, Issue:10

    Topics: Benzamides; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Dasatinib; Drug Discovery; Drug Therapy, Combination; Fusion Proteins, bcr-abl; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Prednisolone; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Thiazoles; Treatment Outcome

2009
Treatment of hypereosinophilic syndromes--the first 100 years.
    Seminars in hematology, 2012, Volume: 49, Issue:2

    Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antigens, CD; Antigens, Neoplasm; Antiviral Agents; Benzamides; CD52 Antigen; Glycoproteins; History, 20th Century; History, 21st Century; Humans; Hydroxyurea; Hypereosinophilic Syndrome; Imatinib Mesylate; Interferon alpha-2; Interferon-alpha; Interleukin-5; Piperazines; Polyethylene Glycols; Prednisolone; Protein Kinase Inhibitors; Pyrimidines; Recombinant Proteins

2012

Trials

1 trial(s) available for prednisolone and s 1033

ArticleYear
Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia.
    Blood, 2015, Aug-06, Volume: 126, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Drug Administration Schedule; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prospective Studies; Pyrimidines; Recurrence; Remission Induction; Survival Analysis; Transplantation, Homologous; Treatment Outcome; Vincristine

2015

Other Studies

3 other study(ies) available for prednisolone and s 1033

ArticleYear
Nilotinib-induced interstitial lung disease.
    International journal of hematology, 2013, Volume: 98, Issue:3

    Topics: Aged; Benzamides; Diagnosis, Differential; Drug Substitution; Female; Glucocorticoids; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung; Lung Diseases, Interstitial; Piperazines; Prednisolone; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Radiography, Thoracic; Time Factors; Tomography, X-Ray Computed; Treatment Outcome

2013
Dasatinib-associated reversible demyelinating peripheral polyneuropathy in a case of chronic myeloid leukemia.
    International journal of hematology, 2018, Volume: 107, Issue:3

    Topics: Acute Disease; Antineoplastic Agents; Dasatinib; Demyelinating Diseases; Drug Substitution; Female; Humans; Immunoglobulins, Intravenous; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Peripheral Nervous System Diseases; Polyneuropathies; Prednisolone; Protein Kinase Inhibitors; Pyrimidines; Treatment Outcome

2018
A case report of nilotinib-induced irreversible interstitial lung disease.
    Medicine, 2022, Jan-28, Volume: 101, Issue:4

    Topics: Adrenal Cortex Hormones; Biopsy; Cough; Humans; Idiopathic Interstitial Pneumonias; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung; Lung Diseases, Interstitial; Male; Middle Aged; Prednisolone; Pyrimidines

2022
chemdatabank.com